- Home
- PPBT
PPBT
Purple Biotech Ltd.
as 01-17-2025 4:00pm EST
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
| Founded: | 2010 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 8.8M | IPO Year: | N/A |
| Target Price: | $126.50 | AVG Volume (30 days): | 117.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.00 - $20.60 | Next Earning Date: | 03-04-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Purple Biotech Ltd. News
PPBT Breaking Stock News: Dive into PPBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire
2 months ago
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire
2 months ago
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer
GlobeNewswire
2 months ago
Purple Biotech Reports Third Quarter 2024 Financial Results
TipRanks
2 months ago
Purple Biotech Unveils Promising Biomarker for Cancer Therapy
GlobeNewswire
2 months ago
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
GlobeNewswire
3 months ago
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
TipRanks
3 months ago
Purple Biotech Unveils CAPTN-3 Cancer Therapy
Compare PPBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PPBT Purple Biotech Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.